Kevin Coveney
Equibles does not estimate personal net worth.
Get an email with a short summary when Enveric Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get ENVB alertsAbout Kevin Coveney
Kevin Coveney is recorded as CFO at Enveric Biosciences, Inc. (ENVB). The newest filing on record that lists Kevin Coveney as CFO at Enveric Biosciences, Inc. (ENVB) is dated April 14, 2026. Enveric Biosciences, Inc. reported in an 8-K filed February 28, 2023 that Kevin Coveney was appointed Chief Financial Officer, effective March 13, 2023. The proxy statement of Enveric Biosciences, Inc. reports total compensation of $678,445 for Kevin Coveney in fiscal 2025, including a base salary of $396,550. Disclosed compensation is on record for 4 fiscal years. Enveric Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enveric Biosciences, Inc. includes David Johnson (CEO and Board Member), Dr. Joseph Tucker (CEO and Board Member), Joseph Tucker (CEO and Board Member) and 7 others.
“Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders, announced today the appointment of Kevin Coveney, CPA, to the position of Chief Financial Officer, effective March 13, 2023.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 14, 2026
Company network
Leadership on record at Enveric Biosciences, Inc.
- David Johnson CEO, Board Member
- Dr. Joseph Tucker CEO, Board Member
- Joseph Tucker CEO, Board Member
- Dave Johnson Chairman
- Michael D. Webb Chairman, Board Member
- Michael Webb Chairman, Board Member
- Carter J. Ward CFO
- John Van Buiten CFO
- Kevin M. Coveney CFO
- Robert Dickey IV CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Enveric Biosciences, Inc. (ENVB) | Chief Financial Officer | $396,550 | $678,445 |
| 2024 | Enveric Biosciences, Inc. (ENVB) | Chief Financial Officer | $385,000 | $478,002 |
| 2023 | Enveric Biosciences, Inc. (ENVB) | Chief Financial Officer | $308,989 | $358,677 |
| 2022 | Enveric Biosciences, Inc. (ENVB) | Chief Financial Officer | — | — |